5Nathanson SD, Zarbo R J, Wachna DL, et al. Microvessels that predict axillary lymph node metastases in patients with breast cancer. Arch Surg,2000,135(5) :586 - 593.
6Kinoshita J, Kitamum K, Kabashima A, et al. Clinical significance of vascular endothelial growth factoroC (VEGF-C) in breast cancer.Breast Cancer Res Treat,2001,66(2) : 159 - 164.
7Wigle JT, Oliver G. Prox-1 function is required for the development of the murine lymphatic system. Cell, 1999,98 (6):769- 779.
8Breiteneder-Geleff S, Soleiman A, Kowaslki H. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic endothelium. Am J Pathol, 1999,152(2) :385 - 394.
9Banerji S,Ni J,Wang SX,et al. LYVE-1 ,a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol, 1999,144(4) :789 - 801.
10Pajusola K, Aprelikova O, Korhonen J, et al. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992,52 (20) : 5738 - 5743.
二级参考文献34
1Cao Y, Linden P, Farnebo J, Cao R, et al. Vascular endothelial growth factor C induces angiogenesis in vivo [J]. Proc Natl Acad Sci U S A, 1998, 95(24):14389-14394.
2Hofmann M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumour cell line [J]. Cancer Res, 1991, 51:5292-5297.
3Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis [J]. Br J Cancer, 1999, 80(1-2):309-313.
4Lymboussaki A, Olofsson B, Eriksson U, et al. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia [J]. Circ Res, 1999,85(11):992-999.
5Roselle J, Eisma BS, Jeffrey D, et al. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma [J]. Am J Surg, 1997, 174: 513-517.
6Dray TG, Hardin NJ, Sofferman RA, et al. Angiogenesis as a prognostic marker in early head and neck cancer [J]. Ann Otol Rhiol Laryngol, 1995; 104:724-729.
7Ari Ristim, Kirsi Narko, Berndt Enholm, et al. Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C [J]. J Biol Chem, 1998, 273:8413-8418.
8Berger DP, Herbstritt L, Dengler WA, et al. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies [J]. Ann Oncol, 1995, 6: 817-825.
9Joukov V, Kumar V, Sorsa T, et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities [J]. J Bio Chem, 1998, 273(12):6599-6602.
10Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane [J]. Dev Biol, 1997,188(1):96-109.
